Prescription medicines are included in the Black Triangle Scheme if they meet one or more of the following criteria: 

  1. 1. The product is newly registered (Type A applications, excluding biosimilar medicines and seasonal influenza vaccines) 
  2. 2. The product is provisionally registered, or has a provisionally registered indication 
  3. 3. The indications of the product have changed to include use in a significantly different:
  4. 4. Population, for example pediatric use 
  5. 5. Disease or condition, for example a change from an oncology indication to a nononcologic indication 

As a sponsor, you may indicate in your application that you expect your product to be included in the scheme

Select Mandate HA
Select Mandate Function